Hosted on MSN48m
NHS England to offer Casgevy for sickle cell disease patients
Charity organisation Sickle Cell Society has described the recommendation as a “major breakthrough” for sickle cell patients.
Investor's Business Daily on MSN42m
Novartis Pares Gains As Its Bread-And-Butter Drug Faces Looming Competition
Novartis stock closed flat Friday after the drugmaker beat fourth-quarter expectations, largely on the back of its heart failure drug Entresto.